# Nora Franzen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nora-franzen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 276 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 6 |
| i10-index | 6 |
| Last Known Institution | Oncode Institute |
| OpenAlex ID | https://openalex.org/A5024823261 |
| ORCID iD | 0000-0002-4539-1709 |
| Works | 25 |

## Researcher papers

- [Impact of organ-on-a-chip technology on pharmaceutical R&D costs](https://scholariq.org/papers/impact-of-organ-on-a-chip-technology-on-pharmaceutical-r-and-amp-d-costs/)
- [Differences in time to patient access to innovative cancer medicines in six European countries](https://scholariq.org/papers/differences-in-time-to-patient-access-to-innovative-cancer-medicines-in-six/)
- [Evidence Underlying Policy Proposals for Sustainable Anticancer Drug Prices](https://scholariq.org/papers/evidence-underlying-policy-proposals-for-sustainable-anticancer-drug-prices/)
- [The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions](https://scholariq.org/papers/the-socioeconomic-impact-of-cancer-on-patients-and-their-relatives-organisation/)
- [Financial toxicity and socioeconomic impact of cancer in Europe](https://scholariq.org/papers/financial-toxicity-and-socioeconomic-impact-of-cancer-in-europe/)
- [Affordable Prices Without Threatening the Oncological R&D Pipeline—An Economic Experiment on Transparency in Price Negotiations](https://scholariq.org/papers/affordable-prices-without-threatening-the-oncological-r-and-amp-d-pipeline-an/)
- [Securing sustainable price levels of innovative anticancer drugs: How to move forward?](https://scholariq.org/papers/securing-sustainable-price-levels-of-innovative-anticancer-drugs-how-to-move/)
- [Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe](https://scholariq.org/papers/targeted-combination-therapies-in-oncology-challenging-regulatory-frameworks/)
- [Socioeconomic impact among and socioeconomic support services for adolescents and young adults with cancer: A European perspective](https://scholariq.org/papers/socioeconomic-impact-among-and-socioeconomic-support-services-for-adolescents/)
- [Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer](https://scholariq.org/papers/early-cost-effectiveness-analysis-of-using-whole-genome-sequencing-for-patients/)
- [Hospital-based real-world evidence in health technology assessment: insights from a scoping review of European, Australian and North American guidance and expert interviews](https://scholariq.org/papers/hospital-based-real-world-evidence-in-health-technology-assessment-insights-from/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)

## Researcher university

- [Oncode Institute](https://scholariq.org/institutions/oncode-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.